National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

IGF-1R inhibitor OSI-906
An orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. IGF-1R inhibitor OSI-906 selectively inhibits IGF-1R, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. Overexpressed in a variety of human cancers, IGFR-1 stimulates cell proliferation, enables oncogenic transformation, and suppresses apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:OSI-906



Previous:idoxuridine, Ifex, ifosfamide, Ifosfamidum, IGF-1R antagonist BMS-754807
Next:IH636 grape seed proanthocyanidin extract, IL-2 plasmid DNA/lipid complex, IL-2 recombinant fusion protein ALT-801, IL-2/Lptn gene-modified allogeneic neuroblastoma tumor cell vaccine, iloprost

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov